KYOTO, Japan, Aug. 01, 2017 -- Nidec Corporation (TSE:6594) (OTC US:NJDCY) (the “Company”) today announced the status of the Company’s own share repurchase under its ongoing repurchase plan resolved at a meeting of the Board of Directors held on January 24, 2017, pursuant to Article 459, Paragraph 1, Item 1 of the Company Law of Japan.
Details are as follows:
Details of Share Repurchase
1. Period of own share repurchase: From July 1, 2017 through July 31, 2017
2. Class of shares: Common stock
3. Number of own shares repurchased: 0
4. Total repurchase amount: 0 yen
Note: The above repurchase information has been prepared on the basis of execution date.
Reference
A) The following details were resolved by the Company’s Board of Directors on January 24, 2017:
1. Class of shares: Common stock
2. Total number of shares that may be repurchased: Up to 5,000,000 shares
(1.69% of total number of shares issued, excluding treasury stock)
3. Total repurchase amount: Up to 50 billion yen
4. Period of repurchase: From January 27, 2017 through January 26, 2018
B) Total number and yen amount of own shares repurchased from January 27, 2017 through July 31, 2017, pursuant to the Board of Directors resolution above:
1. Total number of own shares repurchased: 520,000
2. Total repurchase amount: 5,138,822,700 yen
Contact: Masahiro Nagayasu General Manager Investor Relations +81-75-935-6140 [email protected]


Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Italy Fines Apple €98.6 Million Over App Store Dominance
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 



